On March 9, 2026, Spruce Biosciences, Inc. entered into a new Open Market Sales Agreement with Jefferies to sell its common stock, replacing a previous agreement, which has also been terminated on the same date; additionally, Corwin Dale Hooks was appointed as Chief Commercial Officer with a salary of $480,000 and potential bonuses.